Danaher Corporation $DHR Shares Sold by Strategic Wealth Investment Group LLC

Strategic Wealth Investment Group LLC decreased its position in Danaher Corporation (NYSE:DHR) by 31.0% in the 4th quarter, Holdings Channel reports. The fund owned 52,988 shares of the conglomerate’s stock after selling 23,797 shares during the period. Danaher accounts for 1.5% of Strategic Wealth Investment Group LLC’s holdings, making the stock its 26th biggest holding. Strategic Wealth Investment Group LLC’s holdings in Danaher were worth $12,130,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of DHR. JPL Wealth Management LLC acquired a new stake in Danaher in the third quarter valued at approximately $25,000. Elevated Capital Advisors LLC acquired a new stake in Danaher in the fourth quarter valued at approximately $26,000. WFA of San Diego LLC acquired a new stake in Danaher in the second quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher in the third quarter valued at approximately $27,000. Finally, Financial Life Planners acquired a new stake in Danaher in the third quarter valued at approximately $32,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR opened at $184.45 on Friday. The business’s fifty day moving average price is $181.29 and its 200 day moving average price is $206.19. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The stock has a market capitalization of $130.55 billion, a PE ratio of 35.68, a price-to-earnings-growth ratio of 2.46 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same period last year, the business posted $1.88 earnings per share. Equities research analysts forecast that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on DHR. Citigroup began coverage on shares of Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. Guggenheim lowered their price objective on shares of Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Morgan Stanley reduced their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Finally, Barclays reduced their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $235.14.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.